Stocks · Health care · Pharmaceutical Preparations

OCULAR THERAPEUTIX, INC

OCUL Clue Score42
United States Fiscal year ends December CIK 0001393434
7.54
+0.40%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
7.54 on 9 Oct 2026
16 11 7 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $11.85 14 Oct 2025 $11.23 15 Oct 2025 $11.94 16 Oct 2025 $12.20 17 Oct 2025 $11.84 20 Oct 2025 $12.18 21 Oct 2025 $11.77 22 Oct 2025 $11.34 23 Oct 2025 $11.44 24 Oct 2025 $11.49 27 Oct 2025 $11.55 28 Oct 2025 $11.53 29 Oct 2025 $11.48 30 Oct 2025 $11.82 31 Oct 2025 $11.66 3 Nov 2025 $11.41 4 Nov 2025 $10.90 5 Nov 2025 $10.81 6 Nov 2025 $10.63 7 Nov 2025 $10.85 10 Nov 2025 $10.83 11 Nov 2025 $11.22 12 Nov 2025 $11.49 13 Nov 2025 $11.19 14 Nov 2025 $11.30 17 Nov 2025 $11.89 18 Nov 2025 $11.76 19 Nov 2025 $12.10 20 Nov 2025 $11.72 21 Nov 2025 $12.24 24 Nov 2025 $12.10 25 Nov 2025 $12.13 26 Nov 2025 $12.14 28 Nov 2025 $12.15 1 Dec 2025 $11.71 2 Dec 2025 $11.25 3 Dec 2025 $11.46 4 Dec 2025 $12.43 5 Dec 2025 $12.58 8 Dec 2025 $16.11 9 Dec 2025 $15.95 10 Dec 2025 $15.41 11 Dec 2025 $14.67 12 Dec 2025 $14.56 15 Dec 2025 $14.17 16 Dec 2025 $14.39 17 Dec 2025 $13.72 18 Dec 2025 $12.98 19 Dec 2025 $12.56 22 Dec 2025 $12.96 23 Dec 2025 $12.74 24 Dec 2025 $12.71 26 Dec 2025 $12.56 29 Dec 2025 $12.30 30 Dec 2025 $12.20 31 Dec 2025 $12.14 2 Jan 2026 $11.82 5 Jan 2026 $11.55 6 Jan 2026 $11.25 7 Jan 2026 $11.50 8 Jan 2026 $11.38 9 Jan 2026 $11.26 12 Jan 2026 $10.69 13 Jan 2026 $10.43 14 Jan 2026 $11.07 15 Jan 2026 $11.28 16 Jan 2026 $11.27 20 Jan 2026 $11.45 21 Jan 2026 $11.42 22 Jan 2026 $11.12 23 Jan 2026 $10.27 26 Jan 2026 $10.89 27 Jan 2026 $10.85 28 Jan 2026 $10.28 29 Jan 2026 $9.95 30 Jan 2026 $9.14 2 Feb 2026 $9.15 3 Feb 2026 $8.51 4 Feb 2026 $8.55 5 Feb 2026 $8.91 6 Feb 2026 $9.16 9 Feb 2026 $9.43 10 Feb 2026 $9.03 11 Feb 2026 $9.16 12 Feb 2026 $9.06 13 Feb 2026 $8.88 17 Feb 2026 $6.99 18 Feb 2026 $6.88 19 Feb 2026 $7.03 20 Feb 2026 $7.78 23 Feb 2026 $8.41 24 Feb 2026 $8.96 25 Feb 2026 $9.50 26 Feb 2026 $9.59 27 Feb 2026 $8.94 2 Mar 2026 $10.98 3 Mar 2026 $10.76 4 Mar 2026 $11.04 5 Mar 2026 $10.33 6 Mar 2026 $10.27 9 Mar 2026 $9.94 10 Mar 2026 $9.87 11 Mar 2026 $9.50 12 Mar 2026 $8.87 13 Mar 2026 $8.76 16 Mar 2026 $8.63 17 Mar 2026 $8.68 18 Mar 2026 $8.49 19 Mar 2026 $8.27 20 Mar 2026 $8.18 23 Mar 2026 $8.10 24 Mar 2026 $8.10 25 Mar 2026 $8.33 26 Mar 2026 $8.07 27 Mar 2026 $7.55 30 Mar 2026 $7.40 31 Mar 2026 $8.47 1 Apr 2026 $8.33 2 Apr 2026 $8.49 6 Apr 2026 $8.07 7 Apr 2026 $8.34 8 Apr 2026 $8.42 9 Apr 2026 $9.30 10 Apr 2026 $8.79 13 Apr 2026 $8.86 14 Apr 2026 $8.76 15 Apr 2026 $8.91 16 Apr 2026 $8.86 17 Apr 2026 $9.82 20 Apr 2026 $9.52 21 Apr 2026 $9.32 22 Apr 2026 $9.66 23 Apr 2026 $9.59 24 Apr 2026 $9.49 27 Apr 2026 $9.52 28 Apr 2026 $9.32 29 Apr 2026 $9.21 30 Apr 2026 $9.37 1 May 2026 $9.43 4 May 2026 $9.77 5 May 2026 $9.71 6 May 2026 $9.71 7 May 2026 $9.68 8 May 2026 $9.65 11 May 2026 $9.28 12 May 2026 $9.16 13 May 2026 $9.24 14 May 2026 $9.50 15 May 2026 $9.16 18 May 2026 $8.38 19 May 2026 $7.99 20 May 2026 $8.03 21 May 2026 $8.22 22 May 2026 $8.23 26 May 2026 $8.29 27 May 2026 $8.54 28 May 2026 $9.15 29 May 2026 $9.01 1 Jun 2026 $8.93 2 Jun 2026 $8.31 3 Jun 2026 $8.35 4 Jun 2026 $8.80 5 Jun 2026 $8.25 8 Jun 2026 $8.16 9 Jun 2026 $8.47 10 Jun 2026 $8.74 11 Jun 2026 $8.70 12 Jun 2026 $8.94 15 Jun 2026 $8.99 16 Jun 2026 $8.94 17 Jun 2026 $9.64 18 Jun 2026 $9.43 22 Jun 2026 $9.97 23 Jun 2026 $10.12 24 Jun 2026 $9.85 25 Jun 2026 $9.76 26 Jun 2026 $9.84 29 Jun 2026 $9.90 30 Jun 2026 $9.82 1 Jul 2026 $9.47 2 Jul 2026 $9.64 6 Jul 2026 $9.66 7 Jul 2026 $10.33 8 Jul 2026 $10.27 9 Jul 2026 $10.54 10 Jul 2026 $10.20 13 Jul 2026 $9.88 14 Jul 2026 $9.70 15 Jul 2026 $9.96 16 Jul 2026 $9.17 17 Jul 2026 $8.97 20 Jul 2026 $8.71 21 Jul 2026 $8.93 22 Jul 2026 $8.59 23 Jul 2026 $8.62 24 Jul 2026 $8.51 27 Jul 2026 $8.64 28 Jul 2026 $8.45 29 Jul 2026 $8.36 30 Jul 2026 $8.47 31 Jul 2026 $8.17 3 Aug 2026 $8.40 4 Aug 2026 $8.59 5 Aug 2026 $8.50 6 Aug 2026 $8.74 7 Aug 2026 $9.19 10 Aug 2026 $9.24 11 Aug 2026 $9.76 12 Aug 2026 $10.23 13 Aug 2026 $10.10 14 Aug 2026 $10.04 17 Aug 2026 $10.65 18 Aug 2026 $11.01 19 Aug 2026 $11.73 20 Aug 2026 $11.09 21 Aug 2026 $11.08 24 Aug 2026 $10.78 25 Aug 2026 $10.88 26 Aug 2026 $10.77 27 Aug 2026 $10.82 28 Aug 2026 $10.36 31 Aug 2026 $10.49 1 Sep 2026 $10.57 2 Sep 2026 $10.90 3 Sep 2026 $10.64 4 Sep 2026 $10.64 8 Sep 2026 $11.37 9 Sep 2026 $11.47 10 Sep 2026 $10.62 11 Sep 2026 $10.49 14 Sep 2026 $10.72 15 Sep 2026 $10.19 16 Sep 2026 $9.87 17 Sep 2026 $10.14 18 Sep 2026 $9.99 21 Sep 2026 $9.99 22 Sep 2026 $10.50 23 Sep 2026 $10.00 24 Sep 2026 $9.82 25 Sep 2026 $9.65 28 Sep 2026 $7.66 29 Sep 2026 $7.87 30 Sep 2026 $7.67 1 Oct 2026 $7.29 2 Oct 2026 $6.96 5 Oct 2026 $7.25 6 Oct 2026 $7.34 7 Oct 2026 $7.23 8 Oct 2026 $7.51 9 Oct 2026 $7.54 Saroj Namrata Chief Business Officer Sold on a plan $277.79K 5 Nov 2025 · at $10.74 · 12.9% of stake Nayak Sanjay Chief Strategy Officer Sold on a plan $22.61K 24 Nov 2025 · at $12.04 · 0.7% of stake Kaiser Peter Chief Development Officer Sold on a plan $36.14K 24 Nov 2025 · at $12.02 · 1.5% of stake Heier Jeffrey S. Chief Scientific Officer Sold on a plan $41.77K 24 Nov 2025 · at $12.04 · 1.4% of stake Dugel Pravin See Remarks Sold on a plan $235.14K 24 Nov 2025 · at $12.04 · 0.6% of stake Notman Donald Chief Operating Officer Sold at will $49.86K 2 Feb 2026 · at $9.14 · 1.4% of stake Notman Donald Chief Operating Officer Sold at will $51.54K 4 Feb 2026 · at $8.54 · 1.6% of stake Waheed Nadia Chief Medical Officer Sold on a plan $71.08K 12 Feb 2026 · at $9.04 · 2.4% of stake Nayak Sanjay Chief Strategy Officer Sold on a plan $93.55K 12 Feb 2026 · at $9.04 · 3.0% of stake Notman Donald Chief Operating Officer Sold at will $103.47K 12 Feb 2026 · at $9.04 · 3.0% of stake Dugel Pravin See Remarks Sold on a plan $1.13M 12 Feb 2026 · at $9.04 · 4.0% of stake Waheed Nadia Chief Medical Officer Sold on a plan $27.17K 20 Feb 2026 · at $7.74 · 1.1% of stake LINDSTROM RICHARD L MD Director Bought $461.35K 20 Feb 2026 · at $7.66 · 32.3% of stake Nayak Sanjay Chief Strategy Officer Sold on a plan $14.56K 23 Feb 2026 · at $8.28 · 0.5% of stake Kaiser Peter Chief Development Officer Sold on a plan $23.27K 23 Feb 2026 · at $8.28 · 1.0% of stake Heier Jeffrey S. Chief Scientific Officer Sold on a plan $25.31K 23 Feb 2026 · at $8.28 · 0.9% of stake Dugel Pravin See Remarks Sold on a plan $166.06K 23 Feb 2026 · at $8.28 · 0.7% of stake Nayak Sanjay Chief Strategy Officer Sold on a plan $15.24K 26 May 2026 · at $8.20 · 0.6% of stake Kaiser Peter Chief Development Officer Sold on a plan $24.33K 26 May 2026 · at $8.20 · 1.1% of stake Heier Jeffrey S. Chief Scientific Officer Sold on a plan $24.75K 26 May 2026 · at $8.20 · 0.9% of stake Dugel Pravin See Remarks Sold on a plan $173.48K 26 May 2026 · at $8.20 · 0.8% of stake Waheed Nadia Chief Medical Officer Sold on a plan $122.63K 3 Jun 2026 · at $8.27 · 4.7% of stake Nayak Sanjay Chief Strategy Officer Sold on a plan $20.45K 24 Aug 2026 · at $10.78 · 0.6% of stake Kaiser Peter Chief Development Officer Sold on a plan $32.69K 24 Aug 2026 · at $10.77 · 1.1% of stake Heier Jeffrey S. Chief Scientific Officer Sold on a plan $35.53K 24 Aug 2026 · at $10.78 · 1.0% of stake Dugel Pravin See Remarks Sold on a plan $233.16K 24 Aug 2026 · at $10.77 · 0.9% of stake Notman Donald Chief Operating Officer Sold at will $11.25K 31 Aug 2026 · at $10.24 · 0.3% of stake Kaiser Peter Chief Development Officer Sold on a plan $70.43K 2 Oct 2026 · at $7.05 · 3.8% of stake Heier Jeffrey S. Chief Scientific Officer Sold on a plan $76.63K 2 Oct 2026 · at $7.05 · 3.4% of stake
1 buy4 sales at will24 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$51.95M
Net income
$265.94M
Free cash flow
$216.89M
Operating margin
-519.8%
Net margin
-511.9%
Return on equity
-40.6%
Return on capital
-31.7%
Debt to equity
0.03
Revenue growth, 1 yr
-18.5%
Revenue growth, 5 yr
24.5% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
17M -156M FY20 Fiscal year 2020 Revenue $17.40M Net income $155.64M Margin -894.3% 44M -7M FY21 Fiscal year 2021 Revenue $43.52M Net income $6.55M Margin -15.1% · growth +150.1% 51M -71M FY22 Fiscal year 2022 Revenue $51.49M Net income $71.04M Margin -138.0% · growth +18.3% 58M -81M FY23 Fiscal year 2023 Revenue $58.44M Net income $80.74M Margin -138.1% · growth +13.5% 64M -194M FY24 Fiscal year 2024 Revenue $63.72M Net income $193.51M Margin -303.7% · growth +9.0% 52M -266M FY25 Fiscal year 2025 Revenue $51.95M Net income $265.94M Margin -511.9% · growth -18.5%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
2 Oct 2026 Heier Jeffrey S.
Chief Scientific Officer
Sold on a plan $76.63K 3.4%
2 Oct 2026 Kaiser Peter
Chief Development Officer
Sold on a plan $70.43K 3.8%
31 Aug 2026 Notman Donald
Chief Operating Officer
Sold at will $11.25K 0.3%
24 Aug 2026 Dugel Pravin
See Remarks
Sold on a plan $233.16K 0.9%
24 Aug 2026 Heier Jeffrey S.
Chief Scientific Officer
Sold on a plan $35.53K 1.0%
24 Aug 2026 Kaiser Peter
Chief Development Officer
Sold on a plan $32.69K 1.1%